Clifford Chance advised Fresenius Kabi on the sale. German healthcare major Fresenius SE & Co. KGaA (FSNUF.PK, FSNPF.PK) announced that its operating company Fresenius Kabi transferred...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Mirova (Natixis Investment Managers) on the sale. ENGIE, a world leader in low-carbon energy and services, has agreed to acquire 51% of the...
You must be a Standard 1 Year member to access this content.
Clifford Chance advises P3 Spain Logistic Parks SOCIMI. Spanish REIT (SOCIMI) P3 Spain Logistic Parks, one of the leaders in the Spanish long-term logistics real estate...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Neuraxpharm on the deal. Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announced...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Ardian, a world leading private investment house, on its agreement to sell ASR Wind to Naturgy. Gómez Acebo & Pombo (GA_P) has...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Via Célere on the deal. Spanish residential property developer Via Célere announced the sale of 55% of its residential rental portfolio to...
You must be a Standard 1 Year member to access this content.
